How long someone can stay on pazopanib depends on several factors, including the type of cancer being treated, the person's response to the drug, and how well he or she tolerates it. Pazopanib is commonly used for cancers such as advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma.

Here are some general considerations about its duration:

Response to treatment: If a person responds well to pazopanib and experiences manageable side effects, he or she may take it for months or years. Doctors may adjust the duration based on the progression of the cancer and the patient's overall health.

Side effects: Pazopanib can cause side effects such as high blood pressure, liver enzyme abnormalities, gastrointestinal problems, and fatigue. If side effects become severe or intolerable, the doctor may recommend stopping or adjusting the dose.

Disease progression: Pazopanib is often used as a long-term treatment to control cancer progression. However, if the cancer becomes resistant to the drug or grows despite treatment, the doctor may stop it and consider other treatment options.

Monitoring: Patients taking pazopanib will usually be monitored regularly through blood tests and imaging scans. Based on these results, a doctor will determine how long to continue treatment.

Ultimately, the duration is individual, and decisions about stopping or continuing treatment are made by the oncologist based on the patient's clinical condition. If you are taking pazopanib, it is important to have regular follow-ups to ensure that treatment remains appropriate.